1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Samuel, D. Cheng, H. Riley, P.W. Canutescu, A.A. Bu, Z. Walsh, P.N. Roder, H. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US Proc.Natl.Acad.Sci.USA PNASA6 0040 0027-8424 104 15693 10.1073/PNAS.0703080104 17884987 Solution Structure of the A4 Domain of Factor Xi Sheds Light on the Mechanism of Zymogen Activation. 2007 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 9958.274 COAGULATION FACTOR XI 3.4.21.27 APPLE 4 DOMAIN, RESIDUES 290-379 2 nat polymer PLASMA THROMBOPLASTIN ANTECEDENT, PTA, FXI, FACTOR XI no no FCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGY TLRLCKMDNE FCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGY TLRLCKMDNE A,B polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n HUMAN sample 9606 HOMO SAPIENS repository Initial release Version format compliance Version format compliance 1 0 2007-10-02 1 1 2011-05-08 1 2 2011-07-13 CRYSTAL STRUCTURE OF THE FXIA CATALYTIC DOMAIN IN COMPLEXWITH ECOTINM84R CRYSTAL STRUCTURE OF THE FXIA CATALYTIC DOMAIN IN COMPLEXWITH MUTATED ECOTIN CRYSTAL STRUCTURE OF THE FXIA CATALYTIC DOMAIN IN COMPLEXWITH ECOTIN MUTANT (ECOTINP) CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF THECOAGULATION FACTOR XIA IN COMPLEX WITH BENZAMIDINE (S434A-T475A-K437 MUTANT) CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF COAGULATIONFACTOR XI IN COMPLEX WITH BENZAMIDINE (S434A-T475A-K505MUTANT) CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF COAGULATIONFACTOR XI IN COMPLEX WITH BENZAMIDINE (S434A-T475A-C482S-K437A MUTANT) CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF COAGULATIONFACTOR XI IN COMPLEX WITH KUNITZ PROTEASE INHIBITOR DOMAINOF PROTEASE NEXIN II FACTOR XI CATALYTIC DOMAIN COMPLEXED WITH 2 -GUANIDINO-1-(4-(4,4,5,5-TETRAMETHYL-1 ,3,2-DIOXABOROLAN-2-YL)PHENYL) ETHYLNICOTINATE CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF FACTOR XI INCOMPLEX WITH 4-(GUANIDINOMETHYL )-PHENYLBORONIC ACID CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF FACTOR XI INCOMPLEX WITH (R)-1-(4-(4-( HYDROXYMETHYL)-1,3,2-DIOXABOROLAN-2-YL) PHENETHYL)GUANIDINE CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF COAGULATIONFACTOR XI IN COMPLEX WITH (R)-1 -(4-(4-(HYDROXYMETHYL)-1,3,2-DIOXABOROLAN- 2-YL)PHENYL)GUANIDINE CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF COAGULATIONFACTOR XI IN COMPLEX WITH A PEPTIDOMIMETIC INHIBITOR FACTOR XI CATALYTIC DOMAIN COMPLEXED WITH N -((R)-1-(4-BROMOPHENYL)ETHYL)UREA-ASN-VAL -ARG-ALPHA-KETOTHIAZOLE FACTOR XI COMPLEXED WITH 3-HYDROXYPROPYL 3 -(7-AMIDINONAPHTHALENE-1-CARBOXAMIDO) BENZENESULFONATE CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF COAGULATIONFACTOR XI IN COMPLEX WITH N-(7 -CARBAMIMIDOYL-NAPHTHALEN-1-YL)-3-HYDROXY-2 -METHYL-BENZAMIDE CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF COAGULATIONFACTOR XI IN COMPLEX WITH 6- CARBAMIMIDOYL-4-(3-HYDROXY-2-METHYL- BENZOYLAMINO)-NAPHTHALENE-2-CARBOXYLIC ACID METHYLESTER FACTOR XI COMPLEXED WITH A PYRIMIDINONE INHIBITOR CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF COAGULATIONFACTOR XI IN COMPLEX WITH 2-(5 -BENZYLAMINO-2-METHYLSULFANYL-6-OXO-6H- PYRIMIDIN-1-YL)-N-[4-GUANIDINO-1-(THIAZOLE -2-CARBONYL)-BUTYL]-ACETAMIDE CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF COAGULATIONFACTOR XI IN COMPLEX WITH 2-(5 -AMINO-6-OXO-2-M-TOLYL-6H-PYRIMIDIN-1- YL)-N-[4-GUANIDINO-1-(THIAZOLE-2-CARBONYL )-BUTYL]-ACETAMIDE CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF COAGULATIONFACTOR XI IN COMPLEX WITH N-[4 -GUANIDINO-1-(THIAZOLE-2-CARBONYL)-BUTYL]-2 -{6-OXO-5-[(QUINOLIN-8-YLMETHYL)-AMINO]-2 -M-TOLYL-6H-PYRIMIDIN-1-YL}-ACETAMIDE SOLUTION STRUCTURE OF THE A4 DOMAIN OF BLOOD COAGULATION FACTOR XI PDBE Y PDBE 2006-10-25 REL SIDE-CHAIN ASSIGNMENTS WERE OBTAINED FROM 3D-15N TOCSY-HSQC AND 3D-HCCH-TOCSY . DISTANCE RESTRAINTS WERE OBTAINED FROM CROSS-PEAK VOLUMES IN 3D 15N NOESY-HSQC , 3D- 13C-EDITED NOESY AND HOMONUCLEAR NOESY NO RESTRAINT VIOLATION AND LOWEST ENERGY 1 14 NOESY COSY HNHA CBCANH CBCACONH 6.2 pH 310.0 K REFINEMENT DETAILS CAN BE FOUND IN THE JRNL CITATION ABOVE. CNS 1 90% WATER/10% D2O BRUNGER,ADAMS,CLORE,DELANO,GROS, GROSSE- KUNSTLEVE,JIANG,KUSZEWSKI,NILGES, PANNU,READ, RICE,SIMONSON,WARREN refinement CNS structure solution CNS 600 Bruker DMX PHE 272 n 1 PHE 272 A CYS 273 n 2 CYS 273 A HIS 274 n 3 HIS 274 A SER 275 n 4 SER 275 A SER 276 n 5 SER 276 A PHE 277 n 6 PHE 277 A TYR 278 n 7 TYR 278 A HIS 279 n 8 HIS 279 A ASP 280 n 9 ASP 280 A THR 281 n 10 THR 281 A ASP 282 n 11 ASP 282 A PHE 283 n 12 PHE 283 A LEU 284 n 13 LEU 284 A GLY 285 n 14 GLY 285 A GLU 286 n 15 GLU 286 A GLU 287 n 16 GLU 287 A LEU 288 n 17 LEU 288 A ASP 289 n 18 ASP 289 A ILE 290 n 19 ILE 290 A VAL 291 n 20 VAL 291 A ALA 292 n 21 ALA 292 A ALA 293 n 22 ALA 293 A LYS 294 n 23 LYS 294 A SER 295 n 24 SER 295 A HIS 296 n 25 HIS 296 A GLU 297 n 26 GLU 297 A ALA 298 n 27 ALA 298 A CYS 299 n 28 CYS 299 A GLN 300 n 29 GLN 300 A LYS 301 n 30 LYS 301 A LEU 302 n 31 LEU 302 A CYS 303 n 32 CYS 303 A THR 304 n 33 THR 304 A ASN 305 n 34 ASN 305 A ALA 306 n 35 ALA 306 A VAL 307 n 36 VAL 307 A ARG 308 n 37 ARG 308 A CYS 309 n 38 CYS 309 A GLN 310 n 39 GLN 310 A PHE 311 n 40 PHE 311 A PHE 312 n 41 PHE 312 A THR 313 n 42 THR 313 A TYR 314 n 43 TYR 314 A THR 315 n 44 THR 315 A PRO 316 n 45 PRO 316 A ALA 317 n 46 ALA 317 A GLN 318 n 47 GLN 318 A ALA 319 n 48 ALA 319 A SER 320 n 49 SER 320 A CYS 321 n 50 CYS 321 A ASN 322 n 51 ASN 322 A GLU 323 n 52 GLU 323 A GLY 324 n 53 GLY 324 A LYS 325 n 54 LYS 325 A GLY 326 n 55 GLY 326 A LYS 327 n 56 LYS 327 A CYS 328 n 57 CYS 328 A TYR 329 n 58 TYR 329 A LEU 330 n 59 LEU 330 A LYS 331 n 60 LYS 331 A LEU 332 n 61 LEU 332 A SER 333 n 62 SER 333 A SER 334 n 63 SER 334 A ASN 335 n 64 ASN 335 A GLY 336 n 65 GLY 336 A SER 337 n 66 SER 337 A PRO 338 n 67 PRO 338 A THR 339 n 68 THR 339 A LYS 340 n 69 LYS 340 A ILE 341 n 70 ILE 341 A LEU 342 n 71 LEU 342 A HIS 343 n 72 HIS 343 A GLY 344 n 73 GLY 344 A ARG 345 n 74 ARG 345 A GLY 346 n 75 GLY 346 A GLY 347 n 76 GLY 347 A ILE 348 n 77 ILE 348 A SER 349 n 78 SER 349 A GLY 350 n 79 GLY 350 A TYR 351 n 80 TYR 351 A THR 352 n 81 THR 352 A LEU 353 n 82 LEU 353 A ARG 354 n 83 ARG 354 A LEU 355 n 84 LEU 355 A CYS 356 n 85 CYS 356 A LYS 357 n 86 LYS 357 A MET 358 n 87 MET 358 A ASP 359 n 88 ASP 359 A ASN 360 n 89 ASN 360 A GLU 361 n 90 GLU 361 A PHE 272 n 1 PHE 272 B CYS 273 n 2 CYS 273 B HIS 274 n 3 HIS 274 B SER 275 n 4 SER 275 B SER 276 n 5 SER 276 B PHE 277 n 6 PHE 277 B TYR 278 n 7 TYR 278 B HIS 279 n 8 HIS 279 B ASP 280 n 9 ASP 280 B THR 281 n 10 THR 281 B ASP 282 n 11 ASP 282 B PHE 283 n 12 PHE 283 B LEU 284 n 13 LEU 284 B GLY 285 n 14 GLY 285 B GLU 286 n 15 GLU 286 B GLU 287 n 16 GLU 287 B LEU 288 n 17 LEU 288 B ASP 289 n 18 ASP 289 B ILE 290 n 19 ILE 290 B VAL 291 n 20 VAL 291 B ALA 292 n 21 ALA 292 B ALA 293 n 22 ALA 293 B LYS 294 n 23 LYS 294 B SER 295 n 24 SER 295 B HIS 296 n 25 HIS 296 B GLU 297 n 26 GLU 297 B ALA 298 n 27 ALA 298 B CYS 299 n 28 CYS 299 B GLN 300 n 29 GLN 300 B LYS 301 n 30 LYS 301 B LEU 302 n 31 LEU 302 B CYS 303 n 32 CYS 303 B THR 304 n 33 THR 304 B ASN 305 n 34 ASN 305 B ALA 306 n 35 ALA 306 B VAL 307 n 36 VAL 307 B ARG 308 n 37 ARG 308 B CYS 309 n 38 CYS 309 B GLN 310 n 39 GLN 310 B PHE 311 n 40 PHE 311 B PHE 312 n 41 PHE 312 B THR 313 n 42 THR 313 B TYR 314 n 43 TYR 314 B THR 315 n 44 THR 315 B PRO 316 n 45 PRO 316 B ALA 317 n 46 ALA 317 B GLN 318 n 47 GLN 318 B ALA 319 n 48 ALA 319 B SER 320 n 49 SER 320 B CYS 321 n 50 CYS 321 B ASN 322 n 51 ASN 322 B GLU 323 n 52 GLU 323 B GLY 324 n 53 GLY 324 B LYS 325 n 54 LYS 325 B GLY 326 n 55 GLY 326 B LYS 327 n 56 LYS 327 B CYS 328 n 57 CYS 328 B TYR 329 n 58 TYR 329 B LEU 330 n 59 LEU 330 B LYS 331 n 60 LYS 331 B LEU 332 n 61 LEU 332 B SER 333 n 62 SER 333 B SER 334 n 63 SER 334 B ASN 335 n 64 ASN 335 B GLY 336 n 65 GLY 336 B SER 337 n 66 SER 337 B PRO 338 n 67 PRO 338 B THR 339 n 68 THR 339 B LYS 340 n 69 LYS 340 B ILE 341 n 70 ILE 341 B LEU 342 n 71 LEU 342 B HIS 343 n 72 HIS 343 B GLY 344 n 73 GLY 344 B ARG 345 n 74 ARG 345 B GLY 346 n 75 GLY 346 B GLY 347 n 76 GLY 347 B ILE 348 n 77 ILE 348 B SER 349 n 78 SER 349 B GLY 350 n 79 GLY 350 B TYR 351 n 80 TYR 351 B THR 352 n 81 THR 352 B LEU 353 n 82 LEU 353 B ARG 354 n 83 ARG 354 B LEU 355 n 84 LEU 355 B CYS 356 n 85 CYS 356 B LYS 357 n 86 LYS 357 B MET 358 n 87 MET 358 B ASP 359 n 88 ASP 359 B ASN 360 n 89 ASN 360 B GLU 361 n 90 GLU 361 B author_defined_assembly 2 dimeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 A N TYR 278 A N TYR 7 A O SER 349 A O SER 78 A N GLY 350 A N GLY 79 A O PHE 312 A O PHE 41 A N THR 315 A N THR 44 A O LYS 327 A O LYS 56 A N LEU 330 A N LEU 59 A O ASP 289 A O ASP 18 A N LEU 284 A N LEU 13 A O LYS 340 A O LYS 69 B N TYR 278 B N TYR 7 B O SER 349 B O SER 78 B N GLY 350 B N GLY 79 B O PHE 312 B O PHE 41 B N THR 313 B N THR 42 B O TYR 329 B O TYR 58 B N LEU 332 B N LEU 61 B O GLU 287 B O GLU 16 B N LEU 284 B N LEU 13 B O LYS 340 B O LYS 69 1 A A HA HB2 PHE TYR 311 351 1.19 1 B B HH HD2 TYR PHE 278 283 1.26 1 B B OD2 HZ2 ASP LYS 282 331 1.54 1 A A OD2 HG1 ASP THR 282 313 1.57 1 A A O HG LYS SER 294 295 1.57 1 A A O HG LEU SER 332 333 1.60 2 A A OD2 HZ3 ASP LYS 282 331 1.54 3 B B HB3 HA SER ASP 334 359 1.00 3 B B HD2 HB TYR THR 278 281 1.29 3 A A HB HB2 THR TYR 313 329 1.31 4 A A HB3 HZ CYS PHE 299 312 1.27 4 A A OD2 HG1 ASP THR 282 313 1.58 4 A A OE1 HZ1 GLU LYS 323 325 1.60 5 A A OD1 HZ2 ASP LYS 282 331 1.59 6 B B HA HB2 GLN LEU 310 355 1.17 7 B B HG3 H GLU GLY 323 324 1.31 7 A A OD1 HG1 ASP THR 282 313 1.58 8 B B HA2 HA GLY GLU 336 361 1.23 8 A A OD1 HZ2 ASP LYS 282 331 1.51 9 B B HA3 HB3 GLY SER 285 333 1.24 9 B B HB HB3 THR TYR 313 329 1.29 10 A B HZ3 OE2 LYS GLU 340 287 1.57 10 B B HD1 OD1 HIS ASP 279 280 1.59 12 B B HB HB2 THR TYR 313 329 1.17 12 A A OD1 HZ3 ASP LYS 282 331 1.58 13 B B HA HB CYS VAL 303 307 1.21 13 A B HB2 HG LEU LEU 288 342 1.33 13 B B OD1 HZ2 ASP LYS 282 331 1.55 13 A A HZ1 O LYS GLY 325 326 1.60 13 A B HZ2 OE1 LYS GLU 340 286 1.60 13 B B HD1 OD1 HIS ASP 279 280 1.60 14 B B HE1 HE3 TYR LYS 329 331 1.24 14 A A HD3 HB2 ARG MET 308 358 1.26 14 B B OD1 HZ3 ASP LYS 282 331 1.55 14 B B HH21 O ARG GLU 308 361 1.56 14 A B HZ1 OE2 LYS GLU 340 287 1.59 1 A CYS 273 -176.84 -81.36 1 A HIS 274 -146.38 55.37 1 A SER 275 -47.32 106.07 1 A ASP 280 72.30 -35.48 1 A GLU 286 -128.18 -82.24 1 A SER 295 57.66 110.36 1 A ALA 306 -165.09 113.80 1 A PRO 316 -81.59 42.06 1 A GLN 318 -142.64 -61.20 1 A ALA 319 -69.59 82.18 1 A SER 320 -171.88 -57.85 1 A CYS 321 -150.83 -49.17 1 A LYS 325 -171.86 -178.52 1 A SER 333 71.48 93.56 1 A THR 352 -122.19 -81.83 1 A LEU 353 62.05 -176.48 1 B GLU 286 -111.00 -80.61 1 B ALA 293 -138.79 -68.05 1 B SER 295 64.07 88.63 1 B ALA 306 -174.00 22.69 1 B CYS 309 36.52 85.04 1 B GLN 318 -173.93 -39.38 1 B SER 320 -143.97 -78.63 1 B ASN 322 60.89 -89.66 1 B LYS 325 -79.63 -165.94 1 B SER 333 -141.15 -72.63 1 B SER 334 -24.28 52.79 1 B ASN 335 -103.60 -149.50 1 B PRO 338 -72.64 -74.96 1 B THR 352 -85.62 -112.19 1 B LEU 353 -137.91 -66.68 2 A SER 275 -62.11 97.75 2 A ASP 280 56.93 3.17 2 A GLU 286 -109.34 -76.21 2 A SER 295 71.63 113.77 2 A VAL 307 -72.95 33.57 2 A GLN 310 -139.79 -56.58 2 A PRO 316 -90.58 -62.61 2 A ALA 317 64.93 -83.95 2 A CYS 321 -175.18 -47.66 2 A ASN 322 60.18 -101.51 2 A GLU 323 61.49 -84.23 2 A LYS 325 -149.60 -82.98 2 A LEU 353 67.77 -97.73 2 A ARG 354 -137.76 -30.89 2 B SER 275 -68.24 99.94 2 B GLU 286 -128.64 -87.16 2 B SER 295 65.29 90.10 2 B VAL 307 -68.69 73.26 2 B ASN 322 63.15 -176.11 2 B SER 334 -91.64 -77.63 2 B THR 339 -105.40 74.02 2 B LYS 340 -162.51 105.39 2 B LEU 353 -91.35 -93.76 3 A HIS 274 72.20 135.21 3 A HIS 279 -160.84 -149.69 3 A ASP 280 56.73 16.91 3 A GLU 286 -105.15 -75.85 3 A SER 295 68.48 90.62 3 A VAL 307 -69.59 93.65 3 A PRO 316 -27.64 -62.28 3 A ALA 317 -131.46 -73.94 3 A ALA 319 -79.07 -81.12 3 A CYS 321 39.03 62.31 3 A ASN 322 -169.24 -45.57 3 A GLU 323 63.56 63.90 3 A ARG 345 -69.72 64.79 3 A ASN 360 -38.65 91.29 3 B SER 295 67.99 106.82 3 B ARG 308 -147.07 29.90 3 B GLN 310 -131.69 -67.84 3 B ALA 317 62.40 -171.70 3 B SER 320 -84.61 41.26 3 B CYS 321 72.00 126.94 3 B ASN 322 72.13 100.74 3 B SER 333 -176.18 41.11 3 B LEU 353 67.64 177.41 4 A ASP 280 79.70 -43.52 4 A SER 295 63.34 77.00 4 A ALA 317 60.72 -157.78 4 A GLN 318 -106.31 48.99 4 A ASN 322 70.43 170.17 4 A SER 333 -169.86 57.65 4 B GLU 286 -122.94 -75.06 4 B SER 295 72.43 110.12 4 B ARG 308 -164.09 85.30 4 B GLN 310 -122.86 -56.70 4 B ALA 317 59.62 -83.16 4 B GLN 318 64.96 -75.87 4 B CYS 321 177.83 92.83 4 B ASN 322 71.15 -67.56 4 B LEU 353 48.88 -99.73 5 A HIS 274 66.75 118.19 5 A SER 275 -59.41 106.42 5 A GLU 286 -90.23 -65.81 5 A SER 295 67.71 106.23 5 A GLN 318 66.05 -85.61 5 A ALA 319 170.41 -43.80 5 A SER 320 -170.96 -44.55 5 A ASN 322 74.80 151.31 5 A GLU 323 -78.95 25.72 5 B SER 275 -59.33 102.49 5 B GLU 286 -119.94 -83.14 5 B ALA 293 -110.97 -75.57 5 B SER 295 58.39 105.87 5 B VAL 307 -68.25 83.59 5 B GLN 310 -145.67 -36.30 5 B ALA 317 63.25 -71.58 5 B GLN 318 67.38 -69.02 5 B LYS 325 69.85 -179.80 5 B PRO 338 -55.16 101.93 5 B THR 352 -111.64 -89.37 5 B LEU 353 -142.11 -79.69 6 A ASP 280 72.73 -5.89 6 A SER 295 62.15 63.91 6 A VAL 307 -63.95 77.85 6 A CYS 309 68.46 120.35 6 A ALA 317 60.20 -85.33 6 A GLN 318 51.21 71.13 6 A SER 333 170.64 31.05 6 A ASN 335 -95.12 -150.49 6 A PRO 338 -57.38 107.21 6 A LEU 355 -74.44 20.10 6 B ASP 280 73.94 -48.49 6 B SER 295 67.70 111.43 6 B ALA 319 -141.83 -44.99 6 B SER 320 -147.57 33.27 6 B CYS 321 -114.63 -163.93 6 B ARG 345 -88.65 37.76 6 B LEU 353 45.13 -76.17 6 B MET 358 -89.17 36.90 6 B ASP 359 -101.03 -61.40 7 A SER 275 -66.03 89.60 7 A ASP 280 46.95 26.86 7 A GLU 286 -100.06 -87.93 7 A SER 295 53.05 106.20 7 A VAL 307 -77.07 32.96 7 A GLN 310 -76.47 -87.66 7 A GLN 318 -68.91 99.18 7 A CYS 321 73.44 -44.04 7 A LYS 325 41.08 28.91 7 A PRO 338 -48.36 107.06 7 A LEU 353 179.04 -78.86 7 B HIS 274 73.82 152.47 7 B GLU 286 -117.19 -81.89 7 B SER 295 68.52 104.88 7 B ALA 317 -74.43 -77.77 7 B GLN 318 65.54 -68.18 7 B ALA 319 70.55 152.69 7 B CYS 321 77.57 -67.85 7 B GLU 323 50.00 -82.71 8 A SER 275 -60.55 99.03 8 A GLU 286 -73.22 -72.85 8 A SER 295 62.67 80.46 8 A ARG 308 -145.56 28.00 8 A GLN 310 -138.39 -52.58 8 A ALA 317 62.13 -81.66 8 A GLN 318 -92.83 -76.18 8 A SER 320 -149.91 -71.24 8 A ASN 322 74.61 153.64 8 A SER 333 -154.81 30.32 8 A LEU 353 82.25 137.83 8 A ARG 354 -65.12 0.90 8 A ASP 359 -66.84 1.45 8 B ASP 280 48.04 25.83 8 B GLU 286 -140.65 -70.10 8 B SER 295 64.74 86.84 8 B ALA 306 -90.13 59.37 8 B VAL 307 -68.07 92.48 8 B ARG 308 -165.25 38.49 8 B GLN 318 -98.60 58.75 8 B SER 320 60.79 123.30 8 B CYS 321 73.83 -61.99 8 B GLU 323 -95.09 44.84 8 B LYS 325 73.68 -178.01 8 B SER 334 -82.86 -98.37 8 B ASN 335 -104.35 -79.57 9 A GLU 286 -121.87 -84.73 9 A LYS 294 -60.46 -75.84 9 A HIS 296 -36.32 -71.92 9 A ALA 306 -177.07 23.61 9 A CYS 309 57.55 177.79 9 A GLN 310 -150.74 -46.73 9 A PRO 316 -75.52 -71.66 9 A ALA 317 67.48 -21.54 9 A ALA 319 66.88 -68.15 9 A SER 320 -146.76 -51.12 9 A CYS 321 -176.44 26.43 9 A ASN 322 -153.97 -153.23 9 A LYS 325 67.36 -70.58 9 A LEU 353 -59.40 -9.44 9 B SER 275 -45.99 108.84 9 B GLU 286 -98.42 -65.78 9 B SER 295 63.87 82.91 9 B VAL 307 -69.79 88.33 9 B ARG 308 -168.82 80.65 9 B ALA 317 62.74 -85.63 9 B SER 320 -89.58 -72.07 9 B CYS 321 179.13 -50.11 9 B LYS 357 -68.57 0.06 10 A SER 275 -57.53 99.92 10 A SER 295 67.93 100.76 10 A ARG 308 -106.51 40.37 10 A ALA 317 56.41 -93.52 10 A GLN 318 64.90 -177.26 10 A LYS 325 67.67 -164.81 10 A SER 333 -159.46 84.41 10 A SER 334 -91.71 -92.42 10 A ASN 335 -102.89 -68.18 10 A THR 352 -161.45 -166.59 10 A LEU 353 71.33 -164.75 10 A ASP 359 -84.96 46.21 10 B ASP 280 70.15 -7.75 10 B GLU 286 -105.39 -62.85 10 B SER 295 75.34 111.26 10 B ARG 308 -144.02 16.99 10 B ALA 317 49.86 90.68 10 B GLN 318 -149.47 -53.82 10 B ALA 319 63.92 -99.81 10 B GLU 323 -116.50 58.71 10 B LYS 325 63.53 -172.22 10 B PRO 338 -51.00 106.48 11 A GLU 286 -99.88 -72.62 11 A SER 295 67.11 84.65 11 A ASN 305 -100.77 75.96 11 A ALA 306 73.28 92.83 11 A VAL 307 -48.56 100.51 11 A ALA 317 -109.19 -84.69 11 A GLN 318 66.29 -64.20 11 A SER 320 -141.00 35.33 11 A CYS 321 74.33 110.93 11 A ASN 322 74.35 -72.67 11 A LEU 353 -94.72 -66.58 11 B SER 275 -43.38 108.77 11 B GLU 286 -139.60 -76.48 11 B ALA 293 -157.81 -154.13 11 B SER 295 65.28 93.42 11 B ALA 306 -162.42 102.09 11 B VAL 307 -69.87 87.17 11 B ARG 308 -156.13 42.54 11 B GLN 310 -139.83 -46.31 11 B ALA 319 60.86 -157.58 11 B CYS 321 79.60 -43.23 11 B LYS 325 68.02 -91.48 12 A SER 275 -59.94 104.15 12 A HIS 279 -156.31 -107.19 12 A ASP 280 54.83 9.45 12 A THR 281 -160.15 111.19 12 A GLU 286 -133.80 -93.93 12 A SER 295 64.01 87.20 12 A GLN 310 -109.77 -75.11 12 A ALA 317 52.86 -125.86 12 A SER 320 -156.78 -70.27 12 A ARG 345 -104.48 63.66 12 A ARG 354 -175.73 -63.73 12 B CYS 273 -139.84 -79.77 12 B HIS 274 54.54 -94.90 12 B ASP 280 75.69 -33.87 12 B GLU 286 -131.49 -95.60 12 B SER 295 68.09 88.64 12 B GLN 310 -138.89 -52.36 12 B SER 320 78.46 132.93 12 B GLU 323 59.29 -92.86 12 B LYS 325 56.84 2.93 12 B LEU 353 -40.82 -80.20 13 A SER 275 -62.84 97.18 13 A SER 295 64.97 106.04 13 A VAL 307 -69.50 73.43 13 A CYS 321 67.89 -44.65 13 A THR 352 -89.11 -91.05 13 B SER 295 65.96 110.74 13 B ALA 306 -174.96 31.12 13 B ARG 308 -68.93 99.46 13 B CYS 321 59.73 -99.15 13 B GLU 323 63.05 -83.39 13 B LYS 325 75.47 149.77 13 B SER 333 104.64 70.88 13 B ASN 335 -87.07 -149.04 14 A SER 295 65.02 109.24 14 A ALA 306 -162.10 111.65 14 A GLN 310 -131.19 -74.44 14 A PRO 316 -45.85 -70.13 14 A ALA 317 69.01 -35.52 14 A SER 320 -85.68 -87.16 14 A ASN 322 -172.23 130.70 14 A LYS 325 67.43 -171.83 14 A SER 333 -164.81 53.21 14 A SER 334 -92.54 -83.82 14 A PRO 338 -66.86 -81.58 14 A THR 339 -162.68 79.12 14 B SER 275 -52.89 104.36 14 B ASP 280 56.59 73.31 14 B GLU 286 -93.78 -78.81 14 B SER 295 69.14 100.73 14 B ARG 308 -151.56 59.34 14 B ALA 317 -90.25 41.76 14 B SER 320 -156.11 62.71 14 B ASN 322 175.07 -33.26 14 B GLU 323 51.29 87.42 14 B LYS 325 62.34 -172.36 14 B THR 352 -100.38 -101.71 14 B LEU 353 -131.32 -155.98 COAGULATION FACTOR XI (E.C.3.4.21.27) FXI Apple 4 domain loop-out conformation 1 N N 1 N N A HIS 296 A HIS 25 HELX_P A LYS 301 A LYS 30 1 1 6 A LYS 301 A LYS 30 HELX_P A ALA 306 A ALA 35 1 2 6 A ARG 354 A ARG 83 HELX_P A ASN 360 A ASN 89 5 3 7 B GLU 297 B GLU 26 HELX_P B ASN 305 B ASN 34 5 4 9 B ARG 354 B ARG 83 HELX_P B ASP 359 B ASP 88 1 5 6 disulf 2.036 A CYS 273 A SG CYS 2 1_555 A CYS 356 A SG CYS 85 1_555 disulf 2.047 A CYS 299 A SG CYS 28 1_555 A CYS 328 A SG CYS 57 1_555 disulf 2.039 A CYS 303 A SG CYS 32 1_555 A CYS 309 A SG CYS 38 1_555 disulf 2.030 A CYS 321 A SG CYS 50 1_555 B CYS 321 B SG CYS 50 1_555 disulf 2.038 B CYS 273 B SG CYS 2 1_555 B CYS 356 B SG CYS 85 1_555 disulf 2.041 B CYS 299 B SG CYS 28 1_555 B CYS 328 B SG CYS 57 1_555 disulf 2.050 B CYS 303 B SG CYS 32 1_555 B CYS 309 B SG CYS 38 1_555 HYDROLASE PROTEASE, HYDROLASE, GLYCOPROTEIN, POLYMORPHISM, SERINE PROTEASE, HEPARIN-BINDING, DISEASE MUTATION, FXI / BLOOD COAGULATION / PAN DOMAIN /APPLE DOMAIN / BLOOD COAGULATION, ALTERNATIVE SPLICING FA11_HUMAN UNP 1 P03951 290 379 2J8L 272 361 P03951 A 1 1 90 290 379 2J8L 272 361 P03951 B 1 1 90 5 2 5 2 anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel A SER 276 A SER 5 A HIS 279 A HIS 8 A ILE 348 A ILE 77 A TYR 351 A TYR 80 A PHE 311 A PHE 40 A THR 315 A THR 44 A LYS 327 A LYS 56 A LYS 331 A LYS 60 A LEU 288 A LEU 17 A ALA 292 A ALA 21 A ASP 282 A ASP 11 A LEU 284 A LEU 13 A LYS 340 A LYS 69 A LEU 342 A LEU 71 B PHE 277 B PHE 6 B HIS 279 B HIS 8 B ILE 348 B ILE 77 B GLY 350 B GLY 79 B PHE 311 B PHE 40 B TYR 314 B TYR 43 B CYS 328 B CYS 57 B LEU 332 B LEU 61 B GLU 287 B GLU 16 B VAL 291 B VAL 20 B ASP 282 B ASP 11 B LEU 284 B LEU 13 B LYS 340 B LYS 69 B LEU 342 B LEU 71 1 P 1